SASTASUNDR.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: December 30, 2025
Report Source: 2026 2nd Quarter Report
Health X Platform Ltd. Stock Analysis SASTASUNDR.NS
Sastasundar Ventures Ltd. distributes health care and pharmaceutical products. The company is headquartered in Kolkata, West Bengal and currently employs 1,657 full-time employees. The company went IPO on 2010-10-05. The firm's segments include Financial Services and Healthcare Network. The financial Services segment consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The Health Network segment includes activities for pathology, food processing and marketing of healthcare and over-the-counter products through e-commerce portal and diagnostic services, which consist of pathological/radiological investigations. Its digital platforms for healthcare are Sastasundar Application, which is a consumer-focused digital healthcare platform consisting of pharmacy, diagnostics, and wellness; and retailershakti.com., a business to business (B2B) digital platform for pharmaceutical and wellness products.
Read More Health X Platform Ltd (SASTASUNDR.NS) Chart
Key Statistics of Health X Platform Ltd (SASTASUNDR.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹288.75Volume
2612.00P/E Ratio (TTM)
-52 Week Range
Market Cap
8.56BAvg. Volume
12.76KDividend Yield
-Financial Metrics & Statements of Health X Platform Ltd (SASTASUNDR.NS)
FAQ's for Health X Platform Ltd (SASTASUNDR.NS)
- According to Musaffa’s Shariah screening methodology, Health X Platform Ltd (SASTASUNDR.NS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.